Castleark Management LLC Biomarin Pharmaceutical Inc Transaction History

Castleark Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $167,395 - $203,145	-2,240 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $219,922 - $400,951	-3,060 Reduced 57.74%	2,240 $170,000
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $253,764 - $396,261	3,190 Added 151.18%	5,300 $654,000
Q1 2020 May 13, 2020	BUY	$71.37 - $96.85 $150,590 - $204,353	2,110 New	2,110 $178,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.